The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
Daniel T Myran, Rachael Morton, Beverly-Ann Biggs, Irene Veldhuijzen, Francesco Castelli, Tran Anh, Lukas P Staub, Eric Agbata, Prinon Rahman, Manish Pareek, Teymur Noori, Kevin Pottie
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH | MDPI | Published : 2018
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area (EU/EEA) comprise 5.1% of the total EU/EEA population but account for 25% of total chronic Hepatitis B (CHB) infection. Migrants from high HBV prevalence regions are at the highest risk for CHB morbidity. These migrants are at risk of late detection of CHB complications; mortality and onwards transmission. The aim of this systematic review is to evaluate the effectiveness and cost-effectiveness of CHB screening and vaccination programs among migrants to the EU/EEA. We found no RCTs or direct evidence evaluating the effectiveness of CHB screening on morbidity and mortality of migrants. We ther..View full abstract
Awarded by European Centre for Disease Prevention and Control-EHG Project
European Centre for Disease Prevention and Control-EHG Project No. 2169 "Evidence-based guidance on screening for infectious diseases among migrants to the EU/EEA".